2,901 Shares in AdaptHealth Corp. (NASDAQ:AHCO) Purchased by Assetmark Inc.

Assetmark Inc. purchased a new position in shares of AdaptHealth Corp. (NASDAQ:AHCO) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 2,901 shares of the company’s stock, valued at approximately $28,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Blue Trust Inc. raised its stake in shares of AdaptHealth by 24.1% in the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after acquiring an additional 1,115 shares during the period. Quarry LP raised its stake in shares of AdaptHealth by 4,596.9% in the 3rd quarter. Quarry LP now owns 5,965 shares of the company’s stock valued at $67,000 after acquiring an additional 5,838 shares during the period. CIBC Asset Management Inc purchased a new stake in shares of AdaptHealth in the 3rd quarter valued at approximately $122,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its stake in shares of AdaptHealth by 15.4% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after acquiring an additional 1,690 shares during the period. Finally, LRI Investments LLC raised its stake in shares of AdaptHealth by 32.0% in the 3rd quarter. LRI Investments LLC now owns 15,331 shares of the company’s stock valued at $172,000 after acquiring an additional 3,713 shares during the period. 82.67% of the stock is currently owned by institutional investors and hedge funds.

AdaptHealth Stock Down 0.1 %

Shares of NASDAQ:AHCO opened at $9.60 on Monday. The stock has a market cap of $1.29 billion, a P/E ratio of -5.82, a P/E/G ratio of 1.08 and a beta of 1.30. The firm has a fifty day moving average price of $10.02 and a 200 day moving average price of $10.22. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. AdaptHealth Corp. has a 1-year low of $8.35 and a 1-year high of $11.90.

Analysts Set New Price Targets

AHCO has been the topic of a number of research analyst reports. UBS Group reduced their price target on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a research note on Thursday, February 13th. Truist Financial upped their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the stock a “buy” rating in a research note on Wednesday, February 26th. Royal Bank of Canada upped their target price on shares of AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Canaccord Genuity Group upped their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research note on Wednesday, February 26th. Finally, Robert W. Baird upped their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an “outperform” rating in a research note on Thursday, February 27th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, AdaptHealth has a consensus rating of “Buy” and an average price target of $13.80.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.